8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                  ------------
                                    FORM 8-K
                                  ------------

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


                Date of Report (Date of Earliest Event Reported):
                                 March 30, 2007

                           USANA HEALTH SCIENCES, INC.

             (Exact name of registrant as specified in its charter)

                           Commission File No. 0-21116

              Utah                                     87-0500306

 (State or other jurisdiction of              (IRS Employer Identification

         incorporation)                                  Number)

                           3838 West Parkway Boulevard
                           Salt Lake City, Utah 84120
               (Address of principal executive offices, Zip Code)

       Registrant's telephone number, including area code: (801) 954-7100

   Former name or former address, if changed since last report: Not Applicable


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[] Written communications pursuant to Rule 425 under the Securities Act
    (17 CFR 230.425)

[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    (17 CFR 240.14a-12)

[] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
   Act (17 CFR 240.14d-2(b))

[] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
   Act (17 CFR 240.13e-4(c))



Item 5.02         Departure of Directors or Principal Officers; Election of
                 Directors; Appointment of Principal Officer

(b)  On March 30th, 2007, Denis E. Waitley, a member of the Board of Directors
     of USANA Health Sciences, Inc. (the "Company"), communicated his decision
     to retire from the Board. Dr. Waitley's service as a director will end on
     April 17, 2007.

Item 8.01         Other Events

On March 30th, 2007, the Company issued a press release announcing that Denis E.
Waitley, a member of the Company's Board of Directors, has withdrawn his
nomination for reelection to the Board of Directors. The release also included a
statement from the company regarding allegations made concerning the academic
credentials of Mr. Waitley. A copy of the press release is furnished herewith as
Exhibit 99 to this Current Report on Form 8-K and is incorporated herein by
reference. The Company will also post this document on its corporate website,
www.usanahealthsciences.com, under the "investors" link.

As previously announced in the Company's proxy statement as filed with the
Commission on March 13, 2007, the Company will hold its Annual Meeting of
Shareholders on April 18, 2007. As a result of Mr. Waitley's withdrawal as a
nominee to the Board, any shareholder votes received in favor of the election of
Mr. Waitley at the meeting will be disregarded, and the remaining four directors
previously identified in the proxy statement will continue to stand for
re-election. As a result of Mr. Waitley's becoming unavailable for election,
pursuant to the Company's proxy statement, the Board may reduce the number of
directors, substitute another person for that nominee, or otherwise fill the
vacancy created. Currently, the directors do not plan to substitute another
person to be nominated as a director in connection with the annual meeting.

Item 9.01         Financial Statements and Exhibits

                 (d) Exhibits

Exhibit 99       Press release issued by USANA Health Sciences, Inc. dated March
                 30, 2007 (furnished herewith).

                                       2


SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
     registrant has duly caused this report to be signed on its behalf by
     the undersigned hereunto duly authorized.


                           USANA HEALTH SCIENCES, INC.


                          By:  /s/ Gilbert A. Fuller
                               Gilbert A. Fuller, Chief Financial Officer

Date: April 2, 2007

                                       3

EX-99

                                                                      Exhibit 99

USANA Director Denis E. Waitley Withdraws Nomination for Reelection to the Board
                                  of Directors

    SALT LAKE CITY--(BUSINESS WIRE)--March 30, 2007--USANA Health
Sciences Inc. (NASDAQ:USNA) issued the following statement today
regarding allegations made concerning the academic credentials of
board member, Dr. Denis Waitley:

    "Dr. Denis Waitley has decided not to stand for reelection to the
USANA board of directors. Dr. Waitley recently informed USANA that an
error appeared in his biography listed in the Company's proxy
statement and that he did not in fact earn a masters degree in
Organizational Development from the Naval Post Graduate School in
Monterey, California. Dr. Waitley did confirm that he earned a
Bachelor of Science degree from the United States Naval Academy in
Annapolis, Maryland, and a Ph.D. in Human Behavior from La Jolla
University. Dr. Waitley's board term will end on April 17, 2007, at
which time he will retire as a director of the Company.

    "The board of directors has regretfully acknowledged Denis
Waitley's decision to retire from the board and acknowledges his
contributions to USANA during his tenure as a director."

    Commenting on Dr. Waitley's decision, Dr. Myron Wentz, chairman of
USANA's board of directors, said, "It is with regret that we accept
Dr. Waitley's decision not to stand for reelection. We appreciate all
that Denis has done to help build this great company. Denis's lifetime
of accomplishments speak for themselves."

    About USANA

    USANA develops and manufactures high quality nutritional, personal
care, and weight management products that are sold directly to
Preferred Customers and Associates throughout the United States,
Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea,
Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom.
More information on USANA can be found at
http://www.usanahealthsciences.com.

    CONTACT: Edelman
             Joe Poulos, 312-240-2719 (Media)
             or
             USANA Health Sciences Inc., Salt Lake City
             Riley Timmer, 801-954-7100 (Investor Relations)
             investor.relations@us.usana.com